A rare case of medullary carcinoma of colon: Clinical implications and role of adjuvant therapy

[1] Fatima Z, Sharma P, Youssef B, Krishnan K. Medullary Carcinoma of the Colon: A Histopathologic Challenge. Cureus. 2021 Jun 22;13(6):e15831. doi: 10.7759/cureus.15831. FatimaZ SharmaP YoussefB KrishnanK Medullary Carcinoma of the Colon: A Histopathologic Challenge Cureus 2021 Jun 22 13 6 e15831 10.7759/cureus.15831 Open DOISearch in Google Scholar

[2] Jabbal IS, Nagarajan A, Rivera C, Yaghi M, Liang H, Nahleh Z, et al. Medullary carcinoma of the colon: A comprehensive analysis of the National Cancer Database. Surg Oncol. 2022 Dec;45:101856. doi: 10.1016/j.suronc.2022.101856. Epub 2022 Sep 29. JabbalIS NagarajanA RiveraC YaghiM LiangH NahlehZ Medullary carcinoma of the colon: A comprehensive analysis of the National Cancer Database Surg Oncol 2022 Dec 45 101856 10.1016/j.suronc.2022.101856 Epub 2022 Sep 29. Open DOISearch in Google Scholar

[3] Scott N, West NP, Cairns A, Rotimi O: Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital. Histopathology. 2021, 78:963–969. 10.1111/his.14310 ScottN WestNP CairnsA RotimiO Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital Histopathology 2021 78 963 969 10.1111/his.14310 Open DOISearch in Google Scholar

[4] Al-Ishaq F, Al-Dhaheri M, Toffaha A, Awad S, Rizvi S, AbuNada M, et al. Colonic medullary carcinoma: an exceedingly rare type of colorectal malignancy: a case report and review of the literature. J Med Case Rep. 2023 Nov 1;17(1):483. doi: 10.1186/s13256-023-04228-x. Al-IshaqF Al-DhaheriM ToffahaA AwadS RizviS AbuNadaM Colonic medullary carcinoma: an exceedingly rare type of colorectal malignancy: a case report and review of the literature J Med Case Rep 2023 Nov 1 17 1 483 10.1186/s13256-023-04228-x Open DOISearch in Google Scholar

[5] Kai K, Hidaka H, Nakamura T, Ueda Y, Marutsuka K, Ikeda T, et al. A case of poorly differentiated adenocarcinoma with lymphoid stroma originated in the ascending colon diagnosed as lymphoepithelioma-like carcinoma. Clin J Gastroenterol. 2020 Aug;13(4):538–544. doi: 10.1007/s12328-019-01081-8. Epub 2019 Dec 16. KaiK HidakaH NakamuraT UedaY MarutsukaK IkedaT A case of poorly differentiated adenocarcinoma with lymphoid stroma originated in the ascending colon diagnosed as lymphoepithelioma-like carcinoma Clin J Gastroenterol 2020 Aug 13 4 538 544 10.1007/s12328-019-01081-8 Epub 2019 Dec 16. Open DOISearch in Google Scholar

[6] Winn B, Tavares R, Fanion J, Noble L, Gao J, Sabo E, et al: Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation. Hum Pathol. 2009, 40:398–404. doi: 10.1016/j.humpath.2008.08.014. Epub 2008 Nov 7. WinnB TavaresR FanionJ NobleL GaoJ SaboE Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation Hum Pathol 2009 40 398 404 10.1016/j.humpath.2008.08.014 Epub 2008 Nov 7. Open DOISearch in Google Scholar

[7] Colarossi C, Mare M, La Greca G, De Zuanni M, Colarossi L, Aiello E, et al. Medullary Carcinoma of the Gastrointestinal Tract: Report on Two Cases with Immunohistochemical and Molecular Features. Diagnostics (Basel). 2021 Sep 27;11(10):1775. doi: 10.3390/diagnostics11101775. ColarossiC MareM La GrecaG De ZuanniM ColarossiL AielloE Medullary Carcinoma of the Gastrointestinal Tract: Report on Two Cases with Immunohistochemical and Molecular Features Diagnostics (Basel) 2021 Sep 27 11 10 1775 10.3390/diagnostics11101775 Open DOISearch in Google Scholar

[8] Blakely AM, Nelson RA, Hamilton SA, Lai LL: Sidedness determines clinical characteristics and survival outcomes in medullary adenocarcinoma of the colon. Sci Rep. 2021, 14:20481. doi: 10.1038/s41598-021-99848-y. BlakelyAM NelsonRA HamiltonSA LaiLL Sidedness determines clinical characteristics and survival outcomes in medullary adenocarcinoma of the colon Sci Rep 2021 14 20481 10.1038/s41598-021-99848-y Open DOISearch in Google Scholar

[9] Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, et al. Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. J Clin Oncol. 2022 Mar 10;40(8):892–910. doi: 10.1200/JCO.21.02538. Epub 2021 Dec 22. BaxterNN KennedyEB BergslandE BerlinJ GeorgeTJ GillS Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update J Clin Oncol 2022 Mar 10 40 8 892 910 10.1200/JCO.21.02538 Epub 2021 Dec 22. Open DOISearch in Google Scholar

[10] Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003 Jul 17;349(3):247–57. doi: 10.1056/NEJMoa022289. RibicCM SargentDJ MooreMJ ThibodeauSN FrenchAJ GoldbergRM Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 2003 Jul 17 349 3 247 57 10.1056/NEJMoa022289 Open DOISearch in Google Scholar

[11] Friedman K, Brodsky AS, Lu S, Wood S, Gill AJ, Lombardo K, et al. Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Mod Pathol. 2016 May;29(5):528–41. doi: 10.1038/modpathol.2016.54. Epub 2016 Mar 11. FriedmanK BrodskyAS LuS WoodS GillAJ LombardoK Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment Mod Pathol 2016 May 29 5 528 41 10.1038/modpathol.2016.54 Epub 2016 Mar 11. Open DOISearch in Google Scholar